Daniel Wiseman

17PUBLICATIONS
154CO-AUTHORS
Medical mycologyHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedCellular immunologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|May 07, 2026
From Molecular Complexity to Personalized Care in Chronic Myelomonocytic Leukemia.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Mar 09, 2026
The prevalence and clinical significance of clonal monocytosis.

William Grant Dunn, Michael Charles Sachs, Matteo Maggi

|Jan 02, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulators.

Aristeidis G Telonis, Robert F Stanley, Emmalee R Adelman

Pageof 3

Frequent Collaborators

6 joint publications

Kiran Batta

4 joint publications

Carmelo Gurnari

4 joint publications

Yu-Hung Wang

4 joint publications

Chi-Yuan Yao